Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ashraf El Sherbini"'
Autor:
Shaymaa M. M. Yahyaa, Emad F. Eskander, Olfat G. Shaker, Mervat S. Mohamed, Ahmed A. Abd-Rabou, Ashraf El Sherbini
Publikováno v:
Open Journal of Biochemistry. 1:25-36
Objectives: the current study is concerned with investigating the circulating prolactin and testosterone in HCV genotype-4a patients. Moreover, the present study aimed at exploring the impact of the pegylated-interferon-α plus ribavirin (PEG-IFN-α
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f53f23fa59272bde65df7255823c036f
https://doi.org/10.15764/bioc.2014.01003
https://doi.org/10.15764/bioc.2014.01003
Autor:
Olfat G. Shaker, Shaymaa M.M. Yahya, Mervat S. Mohamed, Emad F. Eskander, Ahmed A. Abd-Rabou, Ashraf El Sherbini
Publikováno v:
Indian Journal of Clinical Biochemistry. 29:3-7
Viral infection with hepatitis C virus (HCV) has a high propensity in becoming chronic and it is the major cause of hepatocellular carcinoma (HCC) worldwide. This review was basically established to illustrate the putative role of the P53 gene Arg72P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f40507501642a6a49fcf103aaabee5c
https://doi.org/10.1007/s12291-013-0317-0
https://doi.org/10.1007/s12291-013-0317-0
Autor:
Emad F. Eskander, Shaymaa M.M. Yahya, Olfat G. Shaker, Mervat S. Mohamed, Ahmed A. Abd-Rabou, Ashraf El Sherbini
Publikováno v:
Genesdiseases. 2(2)
Current estimates indicate that the hepatitis C (HCV) is the leading cause of mortality around the world, with infection rates steadily increasing in Egypt. The dual therapy for this silent epidemic with pegylated-interferon-α2b/ribavirin has marked
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::901266578395a565645383dcc5606ca9
https://pubmed.ncbi.nlm.nih.gov/30258864
https://pubmed.ncbi.nlm.nih.gov/30258864
Autor:
Olfat G. Shaker, Mervat S. Mohamed, Shaymaa M.M. Yahya, Ahmed A. Abd-Rabou, Ashraf El Sherbini, Emad F. Eskander
Publikováno v:
Gene. 550(1)
The hepatitis C virus (HCV), the main cause of morbidity and mortality, is endemic worldwide. HCV causes cirrhosis and other complications that often lead to death. HCV is most common in underdeveloped nations, with the highest prevalence rates in Eg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd06f225269a75845afcf311778420d8
https://pubmed.ncbi.nlm.nih.gov/25108128
https://pubmed.ncbi.nlm.nih.gov/25108128
Autor:
Ahmed A. Abd-Rabou, Ashraf El Sherbini, Emad F. Eskander, Mervat S. Mohamed, Shaymaa M.M. Yahya, Olfat G. Shaker
The prevalence of hepatitis C virus (HCV) infection varies across the world, with the highest percent of infections reported in Middle East, increasingly in Egypt. The current study aimed at examining the bio-statistical correlation and multiple regr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38ea7da8c20a56171dd8a50def52526c
https://europepmc.org/articles/PMC3783911/
https://europepmc.org/articles/PMC3783911/
